Search

everythinglearnresearchcommunity

for

Search:↓

AMT may be more effective than finasteride for hair growth in androgenetic alopecia.

GPIGS peptide increases thick hair growth in balding Japanese men.

The new method improves accuracy in segmenting scalp tissue layers.

AHR ligands could treat inflammatory skin diseases.

PRP shows promise for improving hair growth in early to moderate hair loss but needs standardized methods for consistent results.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Nonablative radiofrequency therapy improves hair density, thickness, and growth rate.

All-trans retinoic acid at high doses harms goat hair growth cells and could be bad for hair growth.

Grasp protein helps maintain skin health after UVB exposure.

Injectable platelet-rich fibrin (I-PRF) is more effective than platelet-rich plasma (PRP) for treating hair loss.

The androgen receptor gene doesn't help identify women likely to have female pattern hair loss.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Alopecia patients have less GPER-1, which might affect hair loss.

PRP is an effective and safe treatment for hair loss.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Platelet-Rich Plasma (PRP) treatment can significantly increase hair count and thickness in people with Androgenetic Alopecia (AGA) with minimal side effects.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.

Combining laser light therapy and growth factor treatment improves hair growth in people with hair loss.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

The new assay can help develop products for hair re-growth.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.

Mutations in the hairless gene cause hair loss and skin cysts in rhesus macaques.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

CAG repeat numbers in the AR gene likely don't affect male pattern baldness in Korean men.

AGA patients have higher heart disease risk.